Carriers of single heterozygous pathogenic variants in SLC12A1, SLC12A3, and KCNJ1 were shown to have a reduced prevalence of hypertension and for SLC12A3 also in lower serum potassium levels. This evidence concerns the gene SLC12A3 and hypertensive disorder.